Join the club for FREE to access the whole archive and other member benefits.

Beta NMN is no longer available as a nutritional supplement in the US market, reports FDA

15-Nov-2022

Key points from article :

Longevity supplement ingredient beta-nicotinamide mononucleotide (NMN) cannot be sold as a dietary supplement in the USA.
NMN has been authorized for investigation as a new drug.
The Council for Responsible Nutrition (CRN) has responded expressing its dismay at the ruling.
The clinical-stage pharma company researching NMN as a drug is Metro International Biotech.
Working on small-molecule NAD+ enhancers that leverage the NAD+ cycle to treat rare diseases and combat aging.
“The FDA’s reasoning and its refusal to provide a date certain when the authorization as a drug occurred just further raise concerns that it is protecting pharma’s interests over consumer welfare,” said CRN President and CEO Steve Mister.
NMN can be used to build NAD+ via a chemical reaction.
High NAD keep us younger and fitter for longer; supplements that boost NAD+ have become increasingly popular.

Likely to be discussions before stock is removed from sale - and should still be available in the UK

Mentioned in this article:

Click on resource name for more details.

Council for Responsible Nutrition (CRN)

Dietary supplement and functional food industry

FDA

Ensuring safety of drugs, medical supplies and food which is used daily.

Steve Mister

President and CEO of the Council for Responsible Nutrition